Sulfinpyrazone

Sulfinpyrazone is a uricosuric agent that competitively inhibits uric acid (Cay-16219) reabsorption in kidney proximal tubules, which is a key mechanism targeted in the treatment of gout. It can also inhibit degranulation of platelets, reducing the release of ADP and thromboxane and diminishing platelet aggregation.Formal Name: 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione. CAS Number: 57-96-5. Synonyms: G-28315, NSC 75925. Molecular Formula: C23H20N2O3S. Formula Weight: 404.5. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 30 mg/ml, DMSO: 30 mg/ml, DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml, Ethanol: 1 mg/ml. lambdamax: 245 nm. SMILES: O=C(N(C1=CC=CC=C1)N2C3=CC=CC=C3)C(CCS(C4=CC=CC=C4)=O)C2=O. InChi Code: InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2. InChi Key: MBGGBVCUIVRRBF-UHFFFAOYSA-N.